Ms. Saffire Krance
Saffire Krance is a third year medical student at Western University. She previously completed an MSc in pharmacology studying clinical biomarkers of Alzheimer’s disease. She has a passion for research improving quality of life in ophthalmoc conditions, and examining causes and possible treatments for retinal and neurodegenerative diseases.
Sessions in which Ms. Saffire Krance participates
Saturday 11 June, 2022
Authors: Saffire H. Krance1, Sohel Somani2, Eric Tam2, Fahmeeda Murtaza2, Hannah Chiu2. 1Schulich School off Medicine and Dentistry, Western University, London, Ontario, Canada, 2Temetry Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.Author Disclosure Block: S.H. Krance: None.
Sessions in which Ms. Saffire Krance attends
Thursday 9 June, 2022
Learning Objectives:At the end of this session participants will be able to:• Apply skills complementing their residency training in handling complications and improving their surgical acumen.
Friday 10 June, 2022
Inspiring women will share their vision with us. You will discover where their contagious enthusiasm might lead you. Let them transform you by their presence and powerful energy. Learning ObjectivesAt the end of this session, participants will be able to:Learn through multifaceted career examplesDiscuss professional pearls and personal accomplishments of high achieversExplore mentorship with women ophthalmologists ...
Saturday 11 June, 2022
Innovation in Retina Research Award Learning ObjectivesAt the end of this symposium, participants will be able to:Identify innovative Canadian retina research proposals and their intended benefitDescribe how using digital innovations in ophthalmology can optimize patie...
Learning Objectives:To review treatment strategies for managing intraocular lens complicationsTo review pearls for performing cataract surgery in patients with corneal conditions.To understand healthcare economics associated with ocular surface disease and cataract surgeryCanMEDS Roles: Medical expert; Scholar
Authors: Saffire H. Krance1, Sohel Somani2, Eric Tam2, Fahmeeda Murtaza2, Hannah Chiu2. 1Schulich School off Medicine and Dentistry, Western University, London, Ontario, Canada, 2Temetry Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.Author Disclosure Block: S.H. Krance: None.
Learning ObjectivesAt the end of this session, participants will be able to:Manage macular edema secondary to retinal vein occlusionDescribe management of peripapillary choroidal melanomasIntegrate new concepts in retinal detachment managementCanMEDS Roles: Medical Expert, Scholar
Learning ObjectivesAt the end of this session, participants will be able to:Describe prognostication for uveal melanomaApply real word data to the management of macular degeneration, diabetic macular edemaAssess patient experiences of inherited retinal diseasesCanMEDS Roles: Medical Expert, Scholar
Sunday 12 June, 2022
LEARNING OBJECTIVESAt the end of this symposium, participants will be able to:Identify the critical unmet needs in neovascular AMD and DME managementDemonstrate a comprehensive understanding of new therapeutic agents and their mechanism of action in nAMD and DME managementExamine how to incorporate new therapeutic options into current management strategies for patients with nAMD and DMEApply new insights from multi-modal imagin...
Learning Objectives:At the end of this session participants will be able to:• Describe the impact of visual impairment on overall health maintenance• Understand the unique aspect of eye health needs in vulnerable populations such as homelessness• Describe the Canadian human resource landscape and challenges augmented by COVID. CanMEDS Roles: Health Advocate, Collaborator
Authors: Milena Cioana, James Im, Yvonne Buys, Hatem Krema, Sophia Liu, Peng Yan, Ya-Ping Jin.Author Disclosure Block: M. Cioana: None. J. Im: None. Y. Buys: Funded grants or clinical trials; Name of for-profit or not-for-profit organization(s); Ontario’s Ministry of Health for the COVID-19 Challenge Questions Initiative; Glaucoma Research Society of Canada. Funded grants or clinical trials; Description of relationship(s); Grant/Research support. H....
Authors: Mariam Issa ,Teresa Park, , Mirriam Mikhail, Sophia Duong, Harleen Bedi, Shangjun Jiang, Victoria Wylson, Gerald Lebovic, Myrna Lichter. Author Disclosure Block: T. Park: None. M. Issa: None. M. Mikhail: None. S. Duong: None. H. Bedi:None. S. Jiang: None. V. Wylson: None. G. Lebovic: None. M. Lichter: None.Abstract Body:Purpose: Poor visual acuity (VA) is heavily correlated wi...
Friday 16 June, 2023
*Breakfast to be served from 6:00am* Learning Objectives:At the end of this session, participants will be able to:Identify innovative canadian retina research proposalsand their intended benefitDescribe how using emerging therapies can improvethe care of patientsCanMEDS Roles: Medical Expert, Scholar
Learning Objectives:At the end of this session, participants will be able to:Review how to apply Quality Improvement strategies to improve patient safetyBe familiar with the presentation and histology of hereditary benign intraepithelial dyskeratosis, and be able to distinguish it from other conjunctival lesions including conjunctival intraepithelial neoplasia.Des...
Our lively Exhibition Hall provides an opportunity for you to reconnect with industry partners to explore the latest treatment options and medical devices available. Be sure to find the COS booth and learn more about See the Possibilities and new Practice Resource Centre features. (And have some fun at our photo wall!)X
Learning Objectives: At the end of this session, participants will be able to: Describe the presenting signs and symptoms, as well as evaluation and management of Giant Cell ArteritisExplain the therapeutic options for central retinal artery occlu...
Learning Objectives: At the end of this session, participants will be able to: Assess new therapeutic modalities for dry age-related macular degenerationAssess current therapies for wet age-related macular degenerationAssess complications of anti-VGF treatments and preventative measuresCanMEDS Roles: Medical Expert, Scholar
Learning Objectives: At the end of this session, participants will be able to: Explain the mechanism of action of the major immune checkpoint inhibitors currently used in cancer immunotherapyDiscuss the
Saturday 17 June, 2023
*Breakfast to be served from 6:00am* Learning Objectives: At the end of this session, participants will be able to: Outline the role of the Tie-2/ang pathway in DR and nAMDand how it may impact patient outcomesIdentify the most important biomarkerson structural OCT that can help predict treatmentresponse in DME and nAMDDiscuss r...
Learning ObjectivesAt the end of this session, participants will be able to:Describe how cultured corneal endothelial cells can be used to treat corneal endothelial failureDescribe how the corneal neurotinization procedure is performed and compare with other treatment modalities for treating neurotrophic corneal ulcersDescribe how cultivated oral mucosal epithelial transplantation can be used to treat patients with Stevens-...
Learning ObjectivesAt the end of this session, participants will be able to:Understand what is meant by cortical visual impairment Appreciate the impact of visual impairment on mental healthBe able to assess the needs of a child with visual impairment CanMEDS Roles: Medical ...
Learning Objectives: At the end of this session, participants will be able to: Describe Choroidal findings in premature babies with ROP Describe the recent recommendations in paediatric CMV screeningDescribe the findings in opti...
Learning ObjectivesAt the end of this session participants will be able to:Describe the impact of AI technologies on eye care Understand the unique aspects of eye health needs in remote populations C...
Learning ObjectivesAt the end of this session participants will be able to:Describe the impact of AI technologies on eye care Understand the unique aspects of eye health needs in remote populationsCompare various models of care for remote populations in low and middle-income countries CanMeds Roles: Professional, Health Advocate